Trial
NCT03002012
Cryptococcal Antigen Screening Plus Sertraline
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Minnesota
Collaborators
Infectious Diseases Institute, Uganda; National Institute of Allergy and Infectious Diseases (NIAID); Mbarara University of Science and Technology
Condition
Cryptococcosis
Intervention
Sertraline
Why stopped
SAEs with n=1 serotonin syndrome, n=2 SAEs after sertraline interruption.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-06-09